Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Dose-Ranging Trial Evaluating the Safety, Tolerability, and Efficacy of LP-10 in Subjects With Symptomatic Oral Lichen Planus

NCT06233591 is registered in ClinicalTrials.gov with Lipella Pharmaceuticals, Inc. as lead sponsor.

NCT NCT06233591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06233591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Dose-Ranging Trial Evaluating the Safety, Tolerability, and Efficacy of LP-10 in Subjects With Symptomatic Oral Lichen Planus
Lead sponsor
Lipella Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
July 1, 2024
Completion date
June 1, 2025
Enrollment
24 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

oral lichen planus